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Orchestrating
the future of clinical care.

Thomas Jefferson University
2005 Annual Report

Mission and Vision

Cover Photo: Sophisticated
microscopes such as the one on
our cover are helping Jefferson
scientists understand how ion
channels – tiny protein pores
through which molecules such
as calcium and potassium flow
in and out of cells – operate.
Members of the voltage-gated ion
channel family are crucial to
generating electrical pulses in the
brain and heart, carrying signals in
nerves and muscles. When channel
function goes awry, the resulting
diseases (including epilepsy, a
number of cardiomyopathies and
cystic fibrosis) can be devastating.
A better understanding of how
these channels work is key to
developing new drugs to treat ion
channel-based disorders.

Mission

Vision

Thomas Jefferson University is dedicated to
the health sciences. We are committed to:

• To be among the premier educators of
healthcare practitioners in the nation

• Educating professionals in a variety of
disciplines who will form and lead the
integrated healthcare delivery and
research teams of tomorrow

• To define the future of clinical care

• Discovering new knowledge that will define
the future of clinical care through
investigation from the laboratory to the
bedside, and into the community
• Setting the standard for quality,
compassionate and efficient patient care
for our community and for the nation
We accomplish our mission in partnership
with Thomas Jefferson University Hospital,
our education and clinical care affiliate.

• To be a major center for patient-oriented
research and clinical trials
• To be a knowledge leader in selected
areas of basic research

A message from Brian G. Harrison and Robert L. Barchi, MD, PhD

T

his is a time of bright promise and new direction for Thomas
Jefferson University. Since 1824, Jefferson has been one of the
nation’s premier educators of healthcare practitioners, a major
center for patient-oriented research and clinical trials, and a
leading clinical care innovator. Today, we confidently master
21st century challenges.
Vital to our success is Jefferson’s Strategic Plan, the scaffolding
supporting essential rebuilding and redirection for the enterprise.
This plan ushers in dramatic changes in education, research, and
clinical care and transforms the university’s physical space. We are
deeply grateful to Jefferson’s faculty, employees and others for
their collective energy and commitment in helping to shape this
framework for the future.
The core of the new Strategic Plan involves imminent physical
changes to Jefferson’s campus, the centerpiece of which will be the
Dorrance H. Hamilton Medical Education Building, a comprehensive
state-of-the-art medical education center and campus green slated
to open in 2007.
The Hamilton Medical Education Building will equip the
University’s medical, nursing, and other healthcare professional
students with the most sophisticated educational tools available
in clinical care today. It will also enable quadrupling the size of the
Dr. Robert and Dorothy Rector Clinical Skills Center, enhancing its
capacity to provide simulated hospital operating and emergency
room training for tomorrow’s professional healthcare teams.
The new building will promote a team-building model among
doctors, nurses, occupational and physical therapists, social workers,
other healthcare professionals and students. It will help us create
a central professional campus – an educational hub – that affords
everyone on the multidisciplinary medical team an opportunity
to learn and work together. (Please see the architectural rendering
on page 12.)
This year, Jefferson Medical College – now the largest private
medical school in the nation – expanded enrollment to 255
students and transformed McClellan Hall into a modern

250+ seat state-of-the-art educational auditorium. A proposed
ambulatory care facility for clinical practices will centralize physician
practices now scattered throughout the campus.
One of the most important steps we can take in shaping a
revitalized Jefferson is to recruit outstanding new leaders to join
our management team to guide future growth. Judith L. Bachman
now fills the newly created post of Senior Vice President for Strategic
Initiatives; Steven E. McKenzie, MD, PhD, is Vice President for
Research; Bruce Metz, PhD, is now the University’s Chief Information
Officer, and Cristina Cavalieri, BSN, Esq., joined Jefferson as Vice
President and University Counsel. As you read this report, our new
Chair of Surgery, Charles J. Yeo, MD, will have joined us from Johns
Hopkins. And renowned cancer researcher, Richard G. Pestell, MD,
PhD, newly arrived from Georgetown University Medical Center,
now heads the Kimmel Cancer Center at Jefferson, providing a
strong administrative and informational link among the university,
medical college and hospital.
Today, with vigorous leadership and a new strategic direction,
we look forward to creating a “community of scholars” – a
campus that brings together all members of the Jefferson
community, and one where practitioners and scientists learn and work
together collaboratively.
We are very proud of every Jeffersonian – our students, faculty,
physicians, researchers, employees, and alumni. Their commitment
to Thomas Jefferson University and its strategic agenda will keep
us keenly focused on positioning Jefferson as a national leader
in healthcare education, research, and clinical care. We dedicate
this report to them and to all who benefit from their knowledge,
skills, and care.

Brian G. Harrison

Robert L. Barchi, MD, PhD

Chair of the Board

President

Cardiology

N

early five million Americans are
living with heart failure, the leading cause of cardiovascular mortality.
More than 550,000 new cases are diagnosed each year. To meet this rising
demand, Jefferson established the Advanced Heart Failure and Cardiac
Transplant Center. The Center, serving more than 1,000 patients, provides
tailored, aggressive heart failure therapy, while offering patients a single
access point for all cardiac needs.
The Center launched its transplant program late last year and is now among the
most active heart transplant programs in the Philadelphia region. Under
the leadership of Director Paul J. Mather, MD, Associate Professor of
Medicine at Jefferson Medical College, staff has completed seven orthotopic
heart transplants and has expanded to satellite offices in Voorhees, New Jersey
and Northeast Philadelphia where patients can receive care for congestive
heart failure and physician follow-up previously unavailable elsewhere in
these communities.
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Jefferson’s research scientists are also fighting cardiovascular disease on many

new fronts:

Director of the Center for Translational Medicine,
Walter J. Koch, PhD, and Andrea D. Eckhart, PhD,
Associate Professor of Medicine, JMC, and Director of
the Center’s Eugene Feiner Laboratory, at the Center’s
mouse echocardiogram. These scientists seek to learn
the causes of congestive heart failure leading to more
effective treatment modalities.

Kumar Sharma, MD, Professor of Medicine
and Director of the Center for Diabetic Kidney
Disease, JMC, along with scientists from
Jefferson and Mount Sinai School of Medicine
in New York, conducted a study that has
identified a protein that plays a leading part
in triggering kidney disease (or diabetic
nephropathy) in patients with diabetes.
Their findings were reported in the journal
PLoS Medicine.

Barry J. Goldstein, MD, Professor of Medicine, Biochemistry and Molecular

Pharmacology, Jefferson Medical College (JMC) oversees research programs
that target mechanisms and regulation of insulin signal transduction,
especially the pathophysiology of insulin-resistant disease states, including
obesity and Type 2 diabetes.
JMC cardiac researchers led by Walter J. Koch, PhD, Director of the Center
for Translational Medicine and W.W. Smith Professor of Medicine, have found
an enzyme in the blood that could be a potential biomarker for congestive
heart failure which affects nearly five million Americans.

Working with Mount Sinai School of Medicine, Kumar Sharma, MD,
Professor of Medicine, JMC, has identified a protein that plays a leading part
in triggering a condition known as diabetic nephropathy and the leading cause
of kidney failure worldwide. Findings from the study could lead to developing
compounds treat diabetic kidney disease.
Bonita Falkner, MD, Professor of Medicine and Pediatrics, JMC, chaired a

National Institutes of Health panel that produced guidelines to treat high
blood pressure in children. Her findings promote routine screening for children
beginning at age 3.
In an attempt to uncover the molecular roots of hypertension, researcher
Andrea Eckhart, PhD, Associate Professor of Medicine, JMC, and Director of

the Center’s Eugene Feiner Laboratory, and her team found that a protein called
GRK5 plays an important role in essential hypertension, which affects
more than 65 million Americans. Overexpressing a mouse gene that makes the
protein led to extreme rises in blood pressure even when the animals were
resting. Coincidentally, researchers found that female mice with an overexpressed GRK5-making gene had a lesser blood pressure spike. Their findings
lead to questions about the protective effects of estrogen.
Education
Jefferson students and cardiology fellows rotate in the Jefferson Heart

Institute’s two-year old nuclear cardiology program where they learn to use
small amounts of radioactive material to assess the heart muscle for known or
suspected coronary artery disease.
Fellowships for the Jefferson Cardiology Fellowship Program remain
extremely competitive, with more than 500 applications for four
available positions this year alone. The 36-month training program
enrolls 12 fellows, and the Accreditation Council for Graduate Medical
Education has approved Jefferson for a fourth-year fellowship program in
interventional cardiology.
Jefferson cardiology residents engage in “mock code” exercises in which the
medical team demonstrates its rapid response when a patient’s heart stops.
Mock code exercises provide active practice and the opportunity to use newly

acquired skills and knowledge while working in multidisciplinary teams. This
training in real-time healthcare services will be able to be expanded when the
Dorrance H. Hamilton Medical Education Building has been completed.
At Jefferson College of Graduate Studies, doctoral candidates have the
opportunity to work in some of the most exciting studies in the nation
under the direction of leading scientific minds such as
new department chairs, Jeffrey L. Benovic, PhD,
Chair of the Department of Biochemistry and
Molecular Biology; Tim Manser, PhD, Chair of the
Department of Microbiology and Immunology;
and Scott Waldman, PhD , Chair of Jefferson’s new
Department of Pharmacology and Experimental
Therapeutics in the Department of Radiologic
Sciences.
Students at Jefferson College of Health Professions
train for work in areas such as cardiac sonography
and vascular sonography, with job placement rates
of 96 percent. The college’s Department of Bioscience
Technologies prepares students for careers in undergraduate and graduate
programs in growth areas such as Biotechnology, Cytotechnology, Medical
Technology, or part-time programs in Molecular Biology, Blood Banking,
Clinical Chemistry, Hematology, and Microbiology to meet the region’s everincreasing demand for well-trained allied health professionals.
Patient Care
Jefferson University Physician cardiologists are at the forefront of diagnosing

heart disease, using advanced non-invasive technologies. In just 30 minutes,
nuclear cardiology's state-of-the-art two-head camera with attenuation correction helps diagnose candidates for revascularization or medical therapy.

During a mock code, students in a
simulation classroom work over
“SimMan,” a mechanical patient
specifically designed for training
students in anesthesia and difficult
airway management.
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Cancer

T

he battle against cancer continues.
In the nearly 35 years since the Federal government declared war on cancer,
enormous progress has been made in the prevention, diagnosis, and treatment
of this disease. Yet for every battle which has been won, many more are still
being fought. Thomas Jefferson University is on the front lines of this war.
The Kimmel Cancer Center at Jefferson – a vibrant, biomedical research and clinical care community – is not only a center of leading-edge cancer research; it
is also a focus of hope for the millions of people who are affected.
Richard G. Pestell, MD, PhD, a noted physician-scientist who specializes in

hormone-related cancers, has recently been appointed Director of the Kimmel
Cancer Center at Jefferson, and is bringing with him a cadre of researchers.
Dr. Pestell was previously the Director of the Lombardi Comprehensive Cancer
Center at Georgetown University in Washington, DC. With Dr. Pestell’s appointment, Jefferson cancer programs are being restructured and the role of the
Cancer Center Director expanded.
Our research scientists are uncovering new weapons that they forecast will
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entirely change the methods of preventing and treating cancer.
Richard G. Pestell, MD, PhD, has
been appointed Director of the
Kimmel Cancer Center at Jefferson,
Professor and Chair of the newly
created Department of Cancer
Biology, Associate Dean for Cancer
Programs at Jefferson Medical
College and Vice President for
Oncology Services at Thomas
Jefferson University Hospital.

Renato Baserga, MD, PhD, who until recently was Interim Director of the

Kimmel Cancer Center at Jefferson, remains a member of the center. He
received the American Cancer Society’s 2004 Scientific Achievement Award.
Dr. Baserga’s lifetime of accomplishment includes the discovery of the
importance of the IGF-1 receptor in cancer. Targeting this receptor, which
helps govern growth in most human cell types, is now the focus of intense
study by cancer researchers around the world. After removing IGF-1 receptors
in cancer cells, Dr. Baserga observed that the cells self-destructed.
Pharmaceutical companies sense the logic in drug development to target the
IGF-1 receptor to kill cancer cells without the toxicity of other therapies.
The groundbreaking T-cell research of Bice Perussia, MD, and Lawrence C.
Eisenlohr, PhD, V.MD, Professors of Microbiology and Immunology at

JMC, holds particular promise for individuals with various leukemias and
immune-related diseases.
Researchers, led by Takami Sato, MD, the Hasumi Associate Professor of
Medicine at JMC, working with Kevin Sullivan, MD, Professor of Radiology,
have shown good results from an early clinical trial of a novel treatment
for melanoma of the eye that has spread to the liver. Immunoembolization blocks off the hepatic artery, the major artery feeding the
liver, cutting off oxygen to liver tumors.
The Molecular Imaging Center is Jefferson’s first state-of-the-art small animal
molecular imaging facility. With advanced technology, Jefferson’s radiologist
researchers can non-invasively image animal models of cardiac disorders,
neurological diseases, malignant and benign tumors, and other medical conditions. Mathew L. Thakur, PhD, Professor of Radiology, was awarded an NIH
grant to examine Cu-64 PET imaging of breast cancer oncogene expression.
The imaging center brings Jefferson to the forefront of the burgeoning
molecular imaging field to enhance care for our patients.
Education
In anticipation of the implementation of the National Boards Step 2
Clinical Skills examination, Jefferson Medical College conducted its first

“high stakes” Objective Structured Clinical Examination (OSCE).
Jefferson’s students performed extremely well in meeting the
rigorous standards set by the faculty. All Jefferson students are now
required to pass the OSCE as a part of their course of study.
Reorganization of oncology services with three oncology departments now
centralized under the Associate Dean for Cancer Programs strengthens
education and training opportunities for our medical students.
Jefferson College of Health Professions expanded its offerings to include

Radiation Therapy and Medical Dosimetry. The college now offers a full range
of imaging modalities, educating students in both diagnosis and treatment
of disease. For students seeking to enter the field of radiologic sciences, the
advantages Jefferson offers are without peer. For instance, we were one of the
earliest in the nation to be accredited by the Joint Review Committee on
Education in Radiologic Technology – the only agency in the field recognized
by the U.S. Department of Education.

Jefferson College of Graduate Studies continues to expand its research in

the areas of molecular and cellular biology, with more than 600 active
research programs receiving approximately $150 million in external
research and training support. Interdepartmental research units, such
as the Jefferson Institute of Molecular Medicine and the Kimmel
Cancer Center at Jefferson, continue to promote a multidisciplinary
approach to biomedical research.
Patient Care
In addition to their focus on research, Jefferson’s world-class cancer

researchers are also deeply committed to helping the next generation of
scientists bring the war on cancer that much closer to victory.
For example, Jefferson’s head and neck surgeons, neurosurgeons and
radiation oncologists are using Novalis® Shaped Beam Surgery™ – the
most advanced radiation technology available anywhere in the world
today – to give new hope to patients with once-untreatable tumors in the
brain and spine.

A clinical rotation in dosimetry at Jefferson
affiliate Christiana Care’s Helen F. Graham
Cancer Center rounds out Jefferson College of
Health Professions’ student Yves Lindo’s training.
Yves and dosimetrist Jodie Noonan take a
moment from their work to enjoy the beauty
of the hospital’s DuPont Garden and pond.

Jefferson University Physician and principal investigator Neal Flomenberg,
MD, Professor of Medicine, JMC, led a Kimmel Cancer Center at Jefferson

clinical trial that concluded that a new drug may help patients with cancer
mobilize the cells necessary to restore their blood-forming system after highdose chemotherapy. They found that patients with multiple myeloma or nonHodgkin’s lymphoma who received the drug AMD-3100 along with the standard drug G-CSF had more stem cells available for transplantation. The
greater number of available stem cells, the more likely transplantation will be
successful. Dr. Flomenberg directs the Bone Marrow Transplant Program at
Jefferson, which celebrated the 10th Anniversary of its first transplant and is
rapidly approaching completion of 500 successful transplants.

A long-term goal of the of the Kimmel Cancer Center at Jefferson’s Zebrafish Laboratory, directed
by Shiu-Ying Ho,PhD, Professor of Microbiology and Immunology, is to better understand the role
of lipid mediators in the normal vertebrate embryo and their influence on intestinal tumor formation
by taking advantage of the unique characteristics of the zebrafish.

Mitchell Machtay, MD, Associate
Professor and Vice Chair of Radiation
Oncology and Director of the
department’s clinical research, has
served as Deputy Group Chair of the
Radiation Therapy Oncology Group
(RTOG), a leading National Cancer
Institute-supported group conducting
clinical trials, since 2000.

Renato Baserga, PhD, (above) Professor of Microbiology
and Immunology, discusses a project in the laboratory with
Mingli Liu, Research Fellow, Kimmel Cancer Center at Jefferson.
Over the next five years, Jefferson will be investing
further effort into laboratory studies to determine which
targeted drugs are best used with what combination of
conventional therapies, and to identify the optimal doses
and appropriate sequence. Underlying Jefferson’s investigation
is the desire to understand the biological underpinnings
and microenvironment of tumors to determine what makes
some sensitive and others resistant to various cancer
regimens. The goal is to find combined modality treatment
with radiation therapy that most effectively discourages
tumor growth and proliferation, with the least side effects,
cell toxicity and drug resistance complications.
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Bone/Connective Tissue

B

ack pain and orthopaedic problems
rank among the most common reasons adults visit a doctor. For some, these
chronic ailments cause significant impairment, keeping them from engaging
fully in their daily activities.
Jefferson has made notable advances in promoting better back, knee, and joint
health. And Thomas Jefferson University physicians and researchers
are helping to maintain this reputation for quality care with their breakthrough
discoveries. With our clinical partner, Thomas Jefferson University Hospital,
ranked the top and only hospital in Philadelphia for orthopaedic care
by U.S. News & World Report, our exceptional combination of groundbreaking research and leading-edge patient care provided by the
outstanding orthopaedic surgeons of the Rothman Institute at Jefferson
contributes to Jefferson’s reputation as a center of orthopaedic excellence.
Zeroing in on Bone and Connective Tissue Disorders
An 11-member orthopaedic research team headed by Irving M. Shapiro,
PhD, Professor of Orthopaedic Surgery at Jefferson Medical College
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Irving M. Shapiro, PhD’s orthopaedic research team
is regenerating spine cells in an oxygen-deprived
environment similar to the body’s own. Equipment
in the background allows researchers to insert their
hands to work without introducing oxygen to the
cell-friendly environment. Their research offers
promise to many who experience pain and disability
from degenerative spinal disease.

Teamwork is what
today’s medicine is all about. Vijay M. Rao, MD,
Chair of Radiology, reports that Radiology’s
musculoskeletal group published extensively,
received a contract to be the independent core
lab to review images for an industry-sponsored
lumbar spine fusion device, and became the
principal investigator of an NCI-funded
cooperative group study using radio-frequency
ablation on bone metastases.

and Director of the Division of Orthopaedic Research, is dedicated to
understanding the cellular and genetic makeup of normal and
abnormal bone and cartilage. Investigating the molecular basis for disk
degeneration using organ culture models, orthopaedic researchers are working
to pinpoint which genes cause regeneration and to develop bone-marrowderived stem cells capable of repopulating and regenerating disks. Their
discovery that spinal disk cells grow better in an oxygen-deprived environment
opens the door to growing disk replacements in the laboratory.

Jefferson orthopaedic researchers are also working to improve orthopaedic
implant materials so replacement hips and knees will last for 30 or 40 years,
and to unravel the causes of degenerative diseases of the skeleton, such as
arthritis and osteoporosis.
In addition, Jefferson’s orthopaedic researchers are focusing on finding the
genes involved in formation of the spine, and are working to prevent scoliosis.
Other research projects seek to identify the molecular changes as bone and cartilage age and to discover how calcium delivery to bones can be improved by
hormones and vitamin D.
In complementary research, Eugene R. Viscusi, MD, Assistant Professor
of Anesthesiology at Jefferson Medical College, has been testing the use of
DepoMorphine, a time-release drug, as a valuable new option for managing
postoperative pain following hip replacement surgery. Dr. Viscusi directs
Jefferson’s Acute Pain Management Service, which plays a key role in promoting a multidisciplinary approach to pain management. The program
involves educating nurses, pharmacists, and physicians from many services.
Education
Jefferson Medical College’s Objective Structured Clinical Exam (OSCE)

ensures that our students meet the highest medical standards in all clinical
services including orthopaedic surgery. The Clinical Skills Center uses
trained standardized patients, analog and digital recording equipment, and
computer tracking and database systems to assess all students’ knowledge and
skills. The program is an integral part of all health professionals’ education
and skill training at Jefferson.
Through its Future Docs program, Jefferson Medical College’s Office of
Diversity and Minority Affairs reaches out to high school students in the
Philadelphia area who express a sincere interest in pursuing a medical career.
Through a series of visits to Jefferson Medical College during which they meet
with medical school representatives, physicians and medical students, these
aspiring high school students get the information and resources they need to
ensure their success as college pre-medical students.
Curricular Changes at the Jefferson College of Graduate Studies now place all
PhD students, from all programs, in a new comprehensive core curriculum

course, entitled “Foundations of Biomedical Science,” where faculty from across
the college teach an integrated introduction to the core fields of biochemistry
and molecular biology, cell biology and genetics.
To meet the growing need for physical therapists, the Jefferson College
of Health Professions has expanded Jefferson’s entry-level Physical Therapy
program to that of a clinical doctorate (DPT). This post-baccalaureate program
not only produces experts in examining and treating musculoskeletal and
neuromuscular problems but also equips physical therapists with skills to
prevent illness and maintain good health and fitness. There are now 107
students enrolled in the college’s physical therapy programs.
Patient Care
At Reconstructive Spine Services at the Rothman Institute at Jefferson
Co-directors Todd Albert, MD, Professor and Vice Chair, Orthopaedic
Surgery, and Alexander R. Vaccaro, MD, Professor of Orthopaedic Surgery, are

testing an artificial disc, composed of metal and plastic, which has produced very favorable results as an alternative to spinal fusion. Jefferson
orthopaedic surgeons performed their first procedure using the artificial
disk this year offering relief for painful degenerated disks.

Jouni Uitto, MD, PhD, Chair of
Dermatology and Cutaneous
Biology, working with junior faculty
researcher, Qiujie Jiang, MD, PhD.
“Much of the current research on
connective tissue diseases is
predicated on the development of
animal models that recapitulate
the clinical phenotypes,” Dr. Uitto
says. “That's really where the state
of the art is now in this field of
research – creating and studying
preclinical disease models.”

7

Neuroscience

J

efferson can boast of having the
first division of neurology in the United States and a long
tradition of excellence in both clinical neurology training
and research. Today, Jefferson students benefit from
leading programs and centers in both the Departments of
Neurosurgery and Neurology at Jefferson Medical College
and an astounding array of new technology.
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At Jefferson Hospital for Neuroscience,
A.M. Rostami, MD, PhD, Professor and
Chair of Neurology, an internationally
renowned expert in the field of multiple
sclerosis and neuroimmunology, leads an
expert group of basic and clinical research
neuroscientists working to find a cure for
multiple sclerosis (MS). Recently, Dr.
Rostami and Guang-Xian Zhang, MD, PhD,
Assistant Professor of Neurology, and
their team found that glucosamine, an
over-the-counter natural product that is
touted to help with joint and cartilage
problems associated with arthritis, helps
improve neurological deficit in a model
of MS. They believe it may also be useful
in the treatment of patients with MS.

The Department of Neurology provides a broad educational approach that promotes clinical and research
strengths in general neurology. Neurologists and
neuroscientists in the Department of Neurology,
including 14 new neurologists, are engaged in extensive
research supported by NIH and other agencies to find the
cause and better treatment for patients with a variety of neurological
disorders including multiple sclerosis (MS), epilepsy, migraine
headache, movement disorders, neuromuscular diseases and stroke.
At the Farber Institute for Neurosciences, located at the Jefferson
Hospital for Neuroscience (JHN), scientists focus on basic research into
the underlying causes of degenerative nervous system diseases such as
Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral
sclerosis (ALS). The Farber Institute, a multidisciplinary neurosciences
research center, continues to build on already-established Jefferson
strengths in these fields, while generating new and revitalized research
programs in others.
As principal investigator of a four-year, $3.5 million grant from the
Pennsylvania Department of Health to support a Center of Excellence on
Neurodegenerative Diseases at the Farber Institute for Neurosciences,
Director Samuel H. Gandy III, MD, PhD, heads a team seeking answers to
questions that resonate for every family. How can a family tell if a loved

one is in the beginning stages of Alzheimer’s disease? Are there changes
individuals can make in their lifestyle to reduce or perhaps delay the effects of
the disease? What can caregivers do to lessen their burden? The new
Jefferson center, co-directed by Barry Rovner, MD. and Laura N. Gitlin,
PhD, will work in collaboration with the Philadelphia Corporation for Aging
to conduct several research projects, each focusing on a different aspect of
Alzheimer’s disease.
Scientists, including Dr. Gandy and Steve Pedrini, PhD, a postdoctoral fellow
in Neurology at Jefferson Medical College and the Farber Institute for
Neurosciences, have taken another step in understanding the potential effects
of anti-cholesterol drugs on Alzheimer’s disease. They have identified
a biochemical pathway that explains the activity of statins, particularly their
ability to break down an early form of the protein amyloid that clusters and
forms sticky plaques in the brain of patients with Alzheimer’s.
Education
As one step in setting up the university’s pioneering research, every fourth
year medical student at Jefferson Medical College now takes a mandatory

Emergency Medical clinical clerkship. This experience exposes Jefferson’s future
doctors and scientist to emergency medical patient care and research in many
instances where serious neurological damage has occurred to patients.
Raymond Regan, MD, Associate Professor in the Department of Emergency

Medicine, JMC, and his postdoctoral assistant, Luna Benvenisti-Zarom, MD,
were recently awarded an American Heart Association grant for their groundbreaking research on a project titled “Optimizing Heme Oxgenase Activity
after CNS Hemorrhage by Adrenoviral-mediated Gene Transfer.”
Jefferson College of Graduate Studies Dean, James H. Keen, PhD, launched

the first Annual Presidential Lecture to be presented annually to showcase the
work of the Jefferson scientific community. In the Inaugural Presidential
Lecture entitled “Musings on Ion Channels, Mutations and Disease,” University
President Robert L. Barchi, MD, PhD, reflected on his experience in identifying
and unraveling the mysteries of ion channels and how their mutations cause
disease. Dr. Barchi expressed his belief that the most exciting and productive
studies include cross-fertilization between researchers and clinicians and that
this exchange was the unique treasure of academic medical centers.

The radiologic sciences play a critical role in neurology and neurosurgery,
helping physicians to diagnose and treat a host of neurological illnesses.
This year, Jefferson College of Health Professions’ Department of Radiologic
Sciences’ MRI Program was among the first in the nation to submit an
application for programmatic accreditation with the Joint Review Committee
on Education in Radiologic Technology. The college also graduated its first
students with the Bachelor of Science degree in Health Services Management,
a part-time BS program for working adults offered through the Department
of General Studies.
Bench-to-Bedside Care for Patients
Jefferson neuroscientists collaborate on many research projects designed to

improve the quality of life for patients with debilitating neurological disorders
such as MS, Alzheimer’s disease, epilepsy, Parkinson’s disease and stroke.

Robert H. Rosenwasser, MD, Professor and Chair of
Neurosurgery and a world-renowned physician specializing
in cerebrovascular neurosurgery and interventional
neuroradiology, continues to solidify Jefferson’s reputation
in stroke with breakthrough procedures such as coiling for
aneurysms and arteriovenous malformations (AVMs).
Research is directed toward innovative approaches in
treating aneurysms and gaining a better understanding
of what is going on in the cellular level inside the aneurysm
after coiling.

An electroencephalogram (EEG) of benign focal epilepsy of the
centrotemporal area in an 11-year-old girl. Recorded during the phase
of light slow sleep, the EEG is printed over a 3D MRI image of the brain
in side view.
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Farber Institute for Neurosciences Director Samuel H. Gandy III,
MD, PhD, an internationally recognized expert in molecular
biology and Alzheimer’s drug discovery, has made it a
priority to establish the Farber Institute as a leading training
center in molecular neuroscience. A new interdisciplinary PhD
Program in Neuroscience, jointly established by the Jefferson
College of Graduate Studies and the Institute, provides hands-on
neuroscience training with internationally recognized scientists
in state-of-the-art research facilities. Elisabeth J. Van Bockstaele,
PhD, Associate Professor of Neurosurgery and Pathology,
Anatomy and Cell Biology, directs the program. Here, Dr. Gandy
confers with technician Emily Sluzs.

Outcomes Research/Community Outreach

J

efferson’s Department of Health

Policy takes great pride in preparing physicians at all levels of training to

meet the challenges of a dynamic healthcare environment. The department’s
chair, David B. Nash, MD, MBA, the Dr. Raymond C. and Doris N. Grandon
Professor of Health Policy, has gained an international reputation for his
work in outcomes management, medical staff development and qualityof-care improvement. Under his leadership, the department contributes to
the quality, safety, and cost-effectiveness of health care. Working shoulder
to shoulder with government policy makers, providers, payers, and other
stakeholders, the department seeks to translate individual patient data
into population health information.
Community Outreach
Students at Jefferson’s three colleges are committed to helping underserved

populations in our community. Their activities range from collecting warm
clothing for the homeless and books for needy children to
going out in the community to provide health care and
literacy programs to those most in need.
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David B. Nash, MD, MBA, the Dr. Raymond C. and
Doris N. Grandon Professor of Health Policy, has gained
an international reputation for his work in outcomes
management, medical staff development and
quality-of-care improvement.

Barry Rovner, MD, Professor of Psychiatry and Human Behavior and Director of
the Division of Geriatric Psychiatry at Jefferson Medical College, co-directs – with
Laura Gitlin, PhD – the university’s Center of Excellence on Neurodegenerative
Diseases at the Farber Institute for Neurosciences. Dr. Gitlin is also Director of the
Center for Applied Research on Aging and Health.

Through JeffHOPE (Health, Opportunity, Prevention
and Education), a student-run organization of
Jefferson Medical College and the Jefferson College of
Health Professions, Jefferson students and faculty provide
dignified, accessible and top-quality health care to the
city’s homeless and underserved populations. At the
same time, the health professional students are given an
opportunity to serve the community while learning
clinical skills and working as members of interdisciplinary
teams in health clinics such as Prevention Point
Philadelphia Center, the Eliza Shirley Shelter House – an
Emergency Center for women and their children, and
Acts of the Apostles Shelter for women and children.

Students at Jefferson College of Graduate Studies formed the Graduate
Student Association (GSA), in part, to link with the college’s surrounding
communities. The GSA has worked with the Franklin Learning Center, a local
high school with a science program, and participates in the American Cancer
Society’s “Making Strides Against Breast Cancer” walk each fall.
To assist our many international students and researchers, Jefferson’s Office
of International Affairs works closely with all University divisions and departments to facilitate exchange and to offer orientation to international visitors.
Rajnish Mago, MD, Assistant Professor of Psychiatry and Director of Mood

Disorder Division helps patients, especially those who have medical illness,
manage depression beyond the office setting.
Education
At Jefferson Medical College, residents are key players in Jefferson’s role

The YES Shelter Outreach
Program, directed by R. Patrick
McManus, MD, Clinical Assistant
Professor of Family Medicine,
received grants from the
Goldsmith-Greenfield
Foundation, Inc., the
Huston Foundation, and
Civic Foundation, Inc. to
help homeless teens.

of providing health services. At the college, the quality of that care is supported
by creating a balance with the duty hour requirements of the Accreditation
Council for Graduate Medical Educations (ACGME) and our residents’ need
to hone their skills and their effectiveness. Dean Thomas J. Nasca, MD, is very
involved in the impact of sleep upon learning.

practitioners in research, policy development, or teaching in the
challenging healthcare environment.

Jefferson’s commitment to producing health professionals best suited
for their roles in the community is evidenced by initiating in 1969
and continuing its commitment to the Jefferson Longitudinal Study. The
Middle States accreditation team said, “The Center for Research in
Medical Education and Health Care and Jefferson Medical College are to be
commended for their academic interest in outcome data, responsiveness
to faculty and department needs, and clear use of data to modify
the curriculum and teaching environment….” More than 90 percent of
residency program directors confirmed among other things that JMC
graduates’ performances lived up to the respective hospital’s expectations.

At Jefferson College of Health Professions the Department of
General Studies hosted Jefferson’s second Summer Science
program in biomedical sciences for high school students. Bringing
together faculty from Jefferson Medical College’s Department
of Anatomy, Pathology and Cell Biology and Jefferson College
of Health Professions’ Department of Bioscience Technologies, the
college presented a program in research techniques pertaining
to molecular biology, cell biology and protein chemistry, pathology and
anatomy and cancer biology. Hopefully, this initiative will lead some of these
students to further education in science related fields.

Jefferson College of Graduate Studies now offers a Master of Science Program

The PACE (Plan A College Education) advanced admission program allows
high school seniors committed to a health professions career to apply to
Jefferson College of Health Professions. If accepted, admission is guaranteed
provided students complete prerequisites and maintain the appropriate grade
point average.

in Public Health providing graduate training, research, and service
opportunities in the primary disciplines of public health: biostatistics, epidemiology, health services administration, health education/behavioral science,
and environmental science. The principal aim is to prepare graduates
to assume or continue professional and leadership roles as public health

Jefferson Medical students receive their white coats.
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Leadership

S

enior management at Jefferson is
moving forward rapidly to put in place the components necessary to fulfill
Jefferson’s vision and implement our strategic agenda while strengthening ties
between the hospital and the university. The energy generated from the planning process has exploded into activity.
Planning
New leaders arrived on campus, while others arose from the ranks, to direct

departments in research and education and to enhance administration and
patient care roles. A campus-wide planning initiative, led by Dr. Barchi and Mr.
Lewis and both Boards of Trustees, identified areas of strength as well as
areas for improvement. As a result, we developed an agenda to both position
Jefferson for the future and create opportunities for Jefferson to reinvent itself.
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The Dorrance H. Hamilton Building,
the healthcare education building
of the future, and a campus green
will soon be a reality on Jefferson’s
campus.

Strengthening the foundation for this metamorphosis was the consolidation
of fundraising for the Hospital, the University and Alumni Office under The
Jefferson Foundation and the development of McClellan Hall as a state-of-theart auditorium to serve our students and thus facilitate the expansion of the
medical school to serve 255 students this year.
Building a Revitalized Campus
At the same time, having identified the University’s strengths in education,

a successful building campaign, anchored by a generous gift from Mrs.
Dorrance H. Hamilton, allowed early groundbreaking for the facility named
for Mrs Hamilton. The healthcare education building of the future and a
campus green will soon be a reality on Jefferson’s campus. Here, healthcare
education will take place in multidisciplinary teams just as real-time
practice demands, making the Jefferson education experience among the most
advanced in the nation.

Restructuring Financial Operations
Recently, Richard J. Schmid, the University’s Vice President for Finance and

Chief Financial Officer, implemented important staff changes to strengthen
Jefferson’s financial position. Scott Ravenfeld is now Senior Director of Finance
for Jefferson Medical College, holding responsibility for the financial operations
within the college. Angelo Veneziano now directs financial operations of
Jefferson College of Health Professions, while Alfred Salvato serves as Associate
Vice President for Finance and Treasurer of the University.
Enhancing Operations at JMC and JUP
As part of strengthening the operations of Jefferson Medical College and to

create a more focused administrative structure, Dean Nasca appointed
John Ogunkeye to the newly created position of Chief Operating Officer for
the Medical College with oversight of the college’s infrastructure. This appointment is designed to enhance the alignment of the college’s business functions
with that of Jefferson University Physicians (JUP) and the University.
At JUP, Mr. Ogunkeye continues to serve as Executive Director and
Vice President for Business Affairs, where he works closely with JUP’s Medical
Director, William M. Keane, MD, and the Executive Committee. Dr. Keane is
also the Herbert Keen, MD, Professor and Chair of Otolaryngology-Head and
Neck Surgery. Their goals are to shape the strategic direction of
the practice plan in coordination with the overall strategic plan and goals
of the University and Hospital.
Research Initiatives
Recently, restructuring of cancer services under Richard G. Pestell, MD, PhD,

as Director of the Kimmel Cancer Center at Jefferson and as the hospital’s
Vice President for Cancer Services, links the university and hospital for information and ease of operation, reinforcing Jefferson’s plan to become a
National Cancer Institute-designated comprehensive cancer center.
It is an exciting time to work at Jefferson and an even more exhilarating time
to participate in leading this outstanding institution.
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(above) Judith Bachman, Senior Vice
President for Strategic Planning and
Steven E. McKenzie, MD, PhD, Senior
Vice President for Research.
(above right) JUP’s Medical Director,
William M. Keane, MD, is also the
Herbert Keen, MD, Professor and
Chair of Otolaryngology-Head and
Neck Surgery.
(right) JUP’s Executive Director and
Vice President for Business Affairs
John Ogunkeye is also Chief Operating
Officer for the Medical College.

Financial Review

How We Spent Our Revenues

How We Received Our Revenues

Physicians’ professional services

Grants and contracts

36.7%

Salaries and wages

51.9%

Employee and faculty benefits

12.5%

24.3%
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Tuition and Fees

10.1%

Sales from auxiliary activities
Endowment payout
State appropriations
Contributions
Other sources

17.8%
1.9%
2.0%
1.2%
6.0%

Depreciation
Heat, light and power
Debt service

Other

3.5%
2.9%
1.1%

28.1%

THOMAS JEFFERSON UNIVERSITY
June 30, 2005 and 2004 ($ in Millions)

2005

%

2004

%

190.4
125.9
52.5
92.1
9.8
10.4
6.4
31.3

36.7%
24.3%
10.1%
17.8%
1.9%
2.0%
1.2%
6.0%

178.1
133.9
47.0
86.4
7.8
10.1
3.7
30.4

35.8%
26.9%
9.4%
17.4%
1.6%
2.0%
0.7%
6.1%

$518.8

100.0%

$497.4

100.0%

267.3
64.5
17.8
15.0
5.9
145.0

51.9%
12.5%
3.5%
2.9%
1.1%
28.1%

259.0
59.6
17.7
14.8
6.1
139.9

52.1%
12.0%
3.6%
3.0%
1.2%
28.1%

$515.5

100.0%

$497.1

100.0%

How We Received Our Revenues

Physicians’ professional services
Grants and contracts
Tuition and Fees
Sales from auxiliary activities
Endowment payout
State appropriations
Contributions
Other sources
Operating Revenues
How We Spent Our Revenues

Salaries and wages
Employee and faculty benefits
Depreciation
Heat, light and power
Debt service
Other
Operating Expenses*

$3.3

$0.3

Non-operating Gains/(Losses), Net

$13.3

$14.2

Tot Non-op loss Net Income/(Loss)

$16.6

$14.5

Subtotal

* Includes depreciation expense on academic facilities
of $17.8 million and $17.7 million for the years ended 2005 and 2004, respectively.

A financial report of Thomas Jefferson University
is available upon request. Please send request to:
Ronald C. Keller, CPA
Controller
Thomas Jefferson University
1020 Walnut Street
Philadelphia, PA 19107-5587
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David R. Lepper

William S. Tasman, MD

Occupational Therapy

Senior Vice President for Development
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Pathology
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Chief Information Officer
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Orthopaedic Surgery

Scott Waldman, MD, PhD

Dean, Jefferson Medical College
Senior Vice President for Academic Affairs

Otolaryngology - Head and Neck Surgery

Penny G. Kroll, PhD, PT

William M. Keane, MD

Physiology

Richard J. Schmid

Marion J. Siegman, PhD

Vice President for Finance, Chief Financial Officer

The Herbert Keen, MD, Professor of
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John P. Sullivan

Pathology

Vice President for Administration

Fred Gorstein, MD
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Dean, Jefferson College of Graduate Studies,
and Vice President for International Affairs

Thomas J. Nasca, MD

Facilities Advisory

Richard C. Gozon
Finance

Peter M. Mattoon, Esq.

Jefferson Medical College
Department Chairs

Pediatrics

Roy Proujansky, MD
The Robert Brent Professor of Pediatrics

Anesthesiology

Governance

Zvi Grunwald , MD

David R. Binswanger

Biochemistry and Molecular Biology

Joint Development Committee

Jeffrey Benovic, PhD

Peter V. Scoles, MD

Cancer Biology

Scientific and Academic Affairs

Richard G. Pestell, MD, PhD

Brian G. Harrison, Co-Chair

Dermatology and Cutaneous Biology
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Emergency Medicine

Jouni J. Uitto, MD, PhD
Theodore A. Christopher, MD, FACEP
Family and Community Medicine

Arthur Michael Feldman, MD, PhD
Magee Professor of Medicine

Jefferson College of Health Professions
Department Chairs
Bioscience Technologies

Shirley E. Greening, JD, CT (ASCP), CFIAC
General Studies

Caroline Golab, PhD
Mary G. Schaal, EdD, RN

Physiology

Occupational Therapy

Marion J. Seigman, PhD

Janice Burke, PhD, OTR/L, FAOTA

Psychiatry and Human Behavior

Physical Therapy

Michael J. Vergare, MD

Penny G. Kroll, PhD, PT

The Daniel Lieberman Professor of Psychiatry
and Human Behavior

Radiologic Sciences

Radiation Oncology

Walter J. Curran Jr., MD
Vijay Rao, MD

Medicine

Physical Therapy

Nursing

Radiology

Dr. Raymond C. and Doris N. Grandon Professor
of Health Policy

Nursing

Scott Waldman, MD, PhD

The Alumni Professor of Family Medicine
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The graduate programs have interdepartmental
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departments:
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Department Chairs
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Rehabilitation Medicine

John L. Melvin, MD, MMSc
The Michie Professor of
Rehabilitation Medicine
Surgery

Charles J. Yeo, MD
The Samuel D. Gross Professor of Surgery
Urology

Leonard G. Gomella, MD
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Meet the Kimmel Cancer Center at Jefferson team –
outstanding professionals who teach, discover and
provide quality, compassionate health care.
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